Pharmacological strategies for the management of comorbid depression and schizophrenia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacological strategies for the management of comorbid depression and schizophrenia

Published:2020-01-27 Issue:4 Volume:21 Page:459-465
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Ceskova Eva¹²³⁴

Affiliation:

1. Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic

2. Department of Psychiatry, University Hospital Brno, Brno, Czech Republic

3. Department of Psychiatry, University Hospital Ostrava, Ostrava, Czech Republic

4. Department of Neurology and Psychiatry, Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2020.1717466

Reference53 articles.

1. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation

2. The burden of depressive symptoms in the long-term treatment of patients with schizophrenia

3. The evolution of depression and suicidality in first episode psychosis

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of second-generation antipsychotics on anxiety/depression in patients with schizophrenia: A systematic review and meta-analysis;Schizophrenia Research;2024-08

2. Dissecting the shared genetic landscape of anxiety, depression, and schizophrenia;Journal of Translational Medicine;2024-04-18

3. Improving depressive symptoms in patients with schizophrenia using bilateral bipolar-nonbalanced prefrontal tDCS: Results from a double-blind sham-controlled trial;Journal of Affective Disorders;2024-03

4. Neuropsychiatric Manifestations in Alzheimer’s Disease Patients: Genetics and Treatment Options;CNS & Neurological Disorders - Drug Targets;2024-01

5. Introduction to Complex Brain Disorders, Currently Available Therapies, and Their Limitations;Application of Nanocarriers in Brain Delivery of Therapeutics;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3